세계의 암치료용 임상 영양 시장 보고서(2024년)

Clinical Nutrition For Cancer Care Global Market Report 2024

US $ 5,000 ￦ 6,926,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,389,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,853,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

암치료용 임상 영양 시장 규모는 향후 몇 년동안 강력한 성장세를 보이며 2028년까지 연평균 5.7%의 성장률로 61억 4,000만 달러에 이를 것으로 예상됩니다. 예측 기간 동안의 성장은 개인 맞춤형 의료와 정밀 영양으로의 전환, 환자를 지원하는 임상 영양 중재에 대한 수요 증가, 영양이 암치료 결과에 미치는 영향에 대한 인식 증가, 암치료의 발전, 암치료에서 구조화된 임상 영양 경로의 통합에 의해 이루어질 것으로 예상됩니다. 예측 기간 동안 주요 동향으로는 영양 바이오마커 연구의 발전, 영양 제품 및 전달 시스템의 기술 혁신, 종양 전문의 간의 협력 강화, 영양 과학의 지속적인 발전, 이 분야의 지속적인 연구 및 개발 등이 있습니다.

암 유병률 증가는 암치료용 임상 영양 시장의 향후 성장을 가속할 것으로 예상됩니다. 암은 통제할 수 없는 세포 증식과 전이 가능성을 특징으로 하는 다양한 질병을 포함합니다. 암 환자 증가는 평균 수명의 연장에 기인하는 바가 크며, 그 결과 고령화 인구가 증가하여 암에 걸리기 쉬운 인구가 증가하고 있습니다. 암치료용 임상 영양은 암 환자의 특성에 맞는 전문적인 식단 관리와 영양 지원을 통해 치료 결과를 최적화하는 것을 포함합니다. 예를 들어, 미국에 본부를 둔 정부 간 기구인 세계보건기구(WHO)는 2024년 2월, 2050년까지 새로 발생하는 암 환자 수를 약 3,500만 명으로 예측했으며, 이는 2022년 추정 환자 수 2,000만 명에서 77% 증가한 수치라고 발표했습니다. 이에 따라 암 유병률 증가는 암치료용 임상 영양제 시장 확대에 박차를 가하고 있습니다.

암치료용 임상 영양 시장의 주요 기업들은 경쟁 우위를 확보하기 위해 경구용 영양 보충제 등 암 환자를 위한 제품을 혁신하고 있습니다. 경구용 영양 보충제는 특정 질환을 앓고 있는 환자들을 위한 맞춤형 영양 지원을 제공하기 위해 특별히 고안된 영양 보충제입니다. 예를 들어, 2022년 7월 스위스에 본사를 둔 식음료 가공업체 네슬레는 중국 최초의 식품 구강영양제인 '푸드 오랄 임팩트 수이수(Food Oral Impact Sui Su)'를 출시했습니다. 이 제품에는 아르기닌과 생선 오메가3가 함유되어 있으며, 중국 규제 당국의 5년에 걸친 승인 과정을 거쳐 종양 관련 질환 환자를 위한 특수 의료 목적(FSMP)을 위한 다른 기본 영양 성분도 포함되어 있습니다. 위해 특별히 승인된 FSMP 영양 보충제입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

• 고인플레이션이 시장에 미치는 영향
• 우크라이나·러시아 전쟁이 시장에 미치는 영향
• 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

• 세계의 암치료용 임상 영양 시장 보고서 2024년 : 촉진요인과 억제요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• 세계의 암치료용 임상 영양 시장 실적 보고서 2024년 : 규모와 성장, 2018-2023년
• 세계의 암치료용 임상 영양 시장 예측 보고서 2024년 : 규모와 성장, 2023-2028년, 2033년

제6장 시장 세분화

• 세계의 암치료용 임상 영양 시장 보고서 2024년 : 유형별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
• 경구 영양
• 비경구 영양 영양
• 경장 영양 포뮬라
• 세계의 암치료용 임상 영양 시장 보고서 2024년 : 암 유형별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
• 두경부암
• 위암 및 소화기암
• 혈액암
• 유방암
• 폐암
• 기타 암 유형
• 세계의 암치료용 임상 영양 시장 보고서 2024년 : 연령층별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
• 성인
• 소아
• 세계의 암치료용 임상 영양 시장 보고서 2024년 : 판매채널별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
• 온라인
• 소매
• 기관투자가용 판매

제7장 지역별/국가별 분석

• 세계의 암치료용 임상 영양 시장 보고서 2024년 : 지역별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
• 세계의 암치료용 임상 영양 시장 보고서 2024년 : 국가별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 암치료용 임상 영양 세계 시장 보고서 2024년 : 경쟁 구도
• 암치료용 임상 영양 세계 시장 보고서 2024년 : 기업 개요
  • Pfizer Inc.
  • Bayer AG
  • Abbott Nutrition
  • GlaxoSmithKline plc
  • Reckitt Benckiser Group plc

제31장 기타 주요 기업 및 혁신 기업

• Evonik Industries AG
• Baxter International Inc.
• Otsuka Holdings Co. Ltd.
• B. Braun Melsungen AG
• Koninklijke DSM N.V.
• Glanbia plc
• Kyowa Kirin Co. Ltd
• Nestle Health Science S.A.
• Danone Nutricia
• BioGaia AB
• Meiji Holdings Company Ltd.
• Hormel Health Labs
• Victus Inc.
• Taiho Pharmaceutical Co. Ltd.
• Global Health Products Inc.

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 향후 전망과 잠재적인 분석

제36장 부록

LSH

영문 목차

영문목차

Clinical nutrition for cancer care involves specialized dietary support and interventions tailored to address the nutritional needs of cancer patients throughout their treatment journey. This includes personalized nutrition plans designed to manage symptoms, optimize treatment outcomes, and enhance the overall quality of life for individuals undergoing cancer therapy.

The primary types of clinical nutrition for cancer care include oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition refers to the consumption of food and fluids by mouth to provide essential nutrients, crucial for supporting those undergoing cancer treatment. This approach is applicable to various cancer types, such as head and neck cancer, stomach and gastrointestinal cancers, blood cancer, breast cancer, lung cancer, and others, for both adults and children. Clinical nutrition for cancer care is distributed through sales channels such as online platforms, retail outlets, and institutional sales.

The clinical nutrition for cancer care market research report is one of a series of new reports from The Business Research Company that provides clinical nutrition for cancer care market statistics, including the clinical nutrition for cancer care industry global market size, regional shares, competitors with the clinical nutrition for cancer care market share, detailed clinical nutrition for cancer care market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical nutrition for cancer care industry. These clinical nutrition for cancer care market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical nutrition for cancer care market size has grown strongly in recent years. It will grow from $4.67 billion in 2023 to $4.92 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth observed in the historic period can be attributed to heightened awareness of nutritional needs, the rise of precision nutrition methods, changes in healthcare policies and reimbursement models, surgical cancer interventions, and increasing interest in functional foods, nutraceuticals, and dietary supplements.

The clinical nutrition for cancer care market size is expected to see strong growth in the next few years. It will grow to $6.14 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period is expected to result from a shift towards personalized medicine and precision nutrition, higher demand for clinical nutrition interventions to support patients, greater awareness of nutrition's impact on cancer treatment outcomes, advancements in cancer treatments, and the integration of structured clinical nutrition pathways in oncology. Key trends for the forecast period include progress in nutritional biomarker research, technological innovations in nutritional products and delivery systems, enhanced collaboration among oncologists, ongoing advancements in nutritional science, and continued research and development in the field.

The increasing prevalence of cancer is expected to drive the growth of the clinical nutrition for cancer care market in the future. Cancer encompasses a range of diseases characterized by uncontrolled cell growth and the potential for metastasis. The rise in cancer cases is largely due to increased life expectancy, resulting in a larger aging population more vulnerable to cancer. Clinical nutrition for cancer care involves specialized dietary management and nutritional support tailored to the unique needs of cancer patients to optimize treatment outcomes. For example, in February 2024, the World Health Organization, an intergovernmental organization based in the US, projected approximately 35 million new cancer cases by 2050, a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing prevalence of cancer is fueling the expansion of the clinical nutrition for cancer care market.

Leading companies in the clinical nutrition for cancer care market are innovating products for cancer patients, such as oral nutritional supplements, to gain a competitive advantage. Oral nutritional supplements are specially formulated dietary products designed to provide targeted nutritional support for individuals with specific medical conditions. For instance, in July 2022, Nestle, a Switzerland-based food and drink processing company, introduced China's first Foods Oral Impact Su Yi Su. This product contains arginine and fish omega-3, along with other basic nutritional ingredients for special medical purposes (FSMP) for patients with tumor-related conditions, following a five-year approval process by the Chinese regulator. Oral Impact Su Yi Su is a FSMP nutritional supplement specifically approved to meet the unique nutritional needs of individuals undergoing cancer treatment.

In January 2024, Danone S.A., a French food-products corporation, partnered with Resilience to create a groundbreaking nutrition and oncology module integrated into Resilience's digital oncology solution. This partnership aims to improve nutritional care for cancer patients by addressing cancer-related malnutrition, which affects up to 70% of cancer patients. Resilience, a US-based digital oncology company, offers clinical nutrition support for cancer patients.

Major companies operating in the clinical nutrition for cancer care market are Pfizer Inc., Bayer AG, Abbott Nutrition, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Evonik Industries AG, Baxter International Inc., Otsuka Holdings Co. Ltd., B. Braun Melsungen AG, Koninklijke DSM N.V., Glanbia plc, Kyowa Kirin Co. Ltd, Nestle Health Science S.A., Danone Nutricia, BioGaia AB, Meiji Holdings Company Ltd., Hormel Health Labs, Victus Inc., Taiho Pharmaceutical Co. Ltd., Global Health Products Inc

North America was the largest region in the clinical nutrition for cancer care market in 2023. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical nutrition for cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical nutrition for cancer care market consists of sales of clinical nutrition products such as high-protein supplements and dietary supplements rich in antioxidants, vitamins, and minerals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Nutrition For Cancer Care Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical nutrition for cancer care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical nutrition for cancer care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical nutrition for cancer care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Oral Nutrition; Parenteral Nutrition; Enteral Feeding Formulas
• 2) By Cancer Type: Head And Neck Cancer; Stomach And Gastrointestinal Cancers; Blood Cancer; Breast Cancer; Lung Cancer; Other Cancer Types
• 3) By Age Group: Adult; Pediatric
• 4) By Sales Channel: Online; Retail; Institutional Sales
• Companies Mentioned: Pfizer Inc.; Bayer AG; Abbott Nutrition; GlaxoSmithKline plc; Reckitt Benckiser Group plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Nutrition For Cancer Care Market Characteristics

3. Clinical Nutrition For Cancer Care Market Trends And Strategies

4. Clinical Nutrition For Cancer Care Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Clinical Nutrition For Cancer Care Market Size and Growth

• 5.1. Global Clinical Nutrition For Cancer Care Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Clinical Nutrition For Cancer Care Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Clinical Nutrition For Cancer Care Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Clinical Nutrition For Cancer Care Market Segmentation

• 6.1. Global Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral Nutrition
• Parenteral Nutrition
• Enteral Feeding Formulas
• 6.2. Global Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Head And Neck Cancer
• Stomach And Gastrointestinal Cancers
• Blood Cancer
• Breast Cancer
• Lung Cancer
• Other Cancer Types
• 6.3. Global Clinical Nutrition For Cancer Care Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Adult
• Pediatric
• 6.4. Global Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Online
• Retail
• Institutional Sales

7. Clinical Nutrition For Cancer Care Market Regional And Country Analysis

• 7.1. Global Clinical Nutrition For Cancer Care Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Clinical Nutrition For Cancer Care Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Clinical Nutrition For Cancer Care Market

• 8.1. Asia-Pacific Clinical Nutrition For Cancer Care Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Clinical Nutrition For Cancer Care Market

• 9.1. China Clinical Nutrition For Cancer Care Market Overview
• 9.2. China Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Clinical Nutrition For Cancer Care Market

• 10.1. India Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Clinical Nutrition For Cancer Care Market

• 11.1. Japan Clinical Nutrition For Cancer Care Market Overview
• 11.2. Japan Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Clinical Nutrition For Cancer Care Market

• 12.1. Australia Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Clinical Nutrition For Cancer Care Market

• 13.1. Indonesia Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Clinical Nutrition For Cancer Care Market

• 14.1. South Korea Clinical Nutrition For Cancer Care Market Overview
• 14.2. South Korea Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Clinical Nutrition For Cancer Care Market

• 15.1. Western Europe Clinical Nutrition For Cancer Care Market Overview
• 15.2. Western Europe Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Clinical Nutrition For Cancer Care Market

• 16.1. UK Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Clinical Nutrition For Cancer Care Market

• 17.1. Germany Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Clinical Nutrition For Cancer Care Market

• 18.1. France Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Clinical Nutrition For Cancer Care Market

• 19.1. Italy Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Clinical Nutrition For Cancer Care Market

• 20.1. Spain Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Clinical Nutrition For Cancer Care Market

• 21.1. Eastern Europe Clinical Nutrition For Cancer Care Market Overview
• 21.2. Eastern Europe Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Clinical Nutrition For Cancer Care Market

• 22.1. Russia Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Clinical Nutrition For Cancer Care Market

• 23.1. North America Clinical Nutrition For Cancer Care Market Overview
• 23.2. North America Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Clinical Nutrition For Cancer Care Market

• 24.1. USA Clinical Nutrition For Cancer Care Market Overview
• 24.2. USA Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Clinical Nutrition For Cancer Care Market

• 25.1. Canada Clinical Nutrition For Cancer Care Market Overview
• 25.2. Canada Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Clinical Nutrition For Cancer Care Market

• 26.1. South America Clinical Nutrition For Cancer Care Market Overview
• 26.2. South America Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Clinical Nutrition For Cancer Care Market

• 27.1. Brazil Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Clinical Nutrition For Cancer Care Market

• 28.1. Middle East Clinical Nutrition For Cancer Care Market Overview
• 28.2. Middle East Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Clinical Nutrition For Cancer Care Market

• 29.1. Africa Clinical Nutrition For Cancer Care Market Overview
• 29.2. Africa Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Clinical Nutrition For Cancer Care Market Competitive Landscape And Company Profiles

• 30.1. Clinical Nutrition For Cancer Care Market Competitive Landscape
• 30.2. Clinical Nutrition For Cancer Care Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Abbott Nutrition
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. GlaxoSmithKline plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Reckitt Benckiser Group plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Clinical Nutrition For Cancer Care Market Other Major And Innovative Companies

• 31.1. Evonik Industries AG
• 31.2. Baxter International Inc.
• 31.3. Otsuka Holdings Co. Ltd.
• 31.4. B. Braun Melsungen AG
• 31.5. Koninklijke DSM N.V.
• 31.6. Glanbia plc
• 31.7. Kyowa Kirin Co. Ltd
• 31.8. Nestle Health Science S.A.
• 31.9. Danone Nutricia
• 31.10. BioGaia AB
• 31.11. Meiji Holdings Company Ltd.
• 31.12. Hormel Health Labs
• 31.13. Victus Inc.
• 31.14. Taiho Pharmaceutical Co. Ltd.
• 31.15. Global Health Products Inc.

32. Global Clinical Nutrition For Cancer Care Market Competitive Benchmarking

33. Global Clinical Nutrition For Cancer Care Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Clinical Nutrition For Cancer Care Market

35. Clinical Nutrition For Cancer Care Market Future Outlook and Potential Analysis

• 35.1 Clinical Nutrition For Cancer Care Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Clinical Nutrition For Cancer Care Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Clinical Nutrition For Cancer Care Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료